This data seem supported recent in vitro study where, in SV40-positive malignant mesothelioma cells, the HGF receptor, the Met oncogene product, was activated promoting the cell-cycle progression into S phase, toward malignant transformation. This evidence concerns the gene MET and malignant mesothelioma.